KD Logo

Chief People Officer Bastone Bronwen sale 18,241 shares of Enfusion Inc [ENFN]

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Enfusion Inc shares valued at $147,935 were sold by Bastone Bronwen on Jun 20 ’24. At $8.11 per share, Bastone Bronwen sold 18,241 shares. The insider’s holdings dropped to 198,913 shares worth approximately $1.71 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Bastone Bronwen sold 10,539 shares, netting a total of over 86,104 in proceeds. Following the sale of shares at $8.17 each, the insider now holds 217,154 shares.

Before that, Campobasso Matthew had sold 1,651 shares from its account. In a trade valued at $13,489, the General Counsel traded Enfusion Inc shares for $8.17 each. Upon closing the transaction, the insider’s holdings decreased to 1,651 shares, worth approximately $0.47 million.

Analysts at Goldman downgraded the stock from ‘”a Neutral”‘ to ‘”a Sell”‘ outlook in a report released in late February. As of January 30, 2024, JP Morgan has decreased its “Neutral” rating to a “an Underweight” for ENFN. Earlier on November 07, 2023, UBS initiated its rating. Their recommendation was “a Neutral” for ENFN stock.

Analyzing ENFN Stock Performance

During the last five days, there has been a surge of approximately 2.14%. Over the course of the year, Enfusion Inc shares have dropped approximately -11.55%. Shares of the company reached a 52-week high of $9.87 on 05/07/24 and a 52-week low of $7.52 on 01/30/24. A 50-day SMA is recorded $9.04, while a 200-day SMA reached $9.08. Nevertheless, trading volume fell to 0.12 million shares from 0.25 million shares the previous day.

Support And Resistance Levels for Enfusion Inc (ENFN)

According to the 24-hour chart, there is a support level at 8.44, which, if violated, would cause prices to drop to 8.31. In the upper region, resistance lies at 8.67. The next price resistance is at 8.77. RSI (Relative Strength Index) is 46.98 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.07, which suggests the price will decrease in the coming days. Percent R is at 13.85%, indicating bullish price movement. Stochastics%K at holding indicates that the stock is to be held.

Most Popular